The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
SIRT3 Is a Mitochondria-Localized Tumor Suppressor Required for Maintenance of Mitochondrial Integrity and Metabolism during Stress
Open accessAbstract
The sirtuin gene family (SIRT) is hypothesized to regulate the aging process and play a role in cellular repair. This work demonstrates that SIRT3(-/-) mouse embryonic fibroblasts (MEFs) exhibit abnormal mitochondrial physiology as well as increases in stress-induced superoxide levels and genomic instability. Expression of a single oncogene (Myc or Ras) in SIRT3(-/-) MEFs results in in vitro transformation and altered intracellular metabolism. Superoxide dismutase prevents transformation by a single oncogene in SIRT3(-/-) MEFs and reverses the tumor-permissive phenotype as well as stress-induced genomic instability. In addition, SIRT3(-/-) mice develop ER/PR-positive mammary tumors. Finally, human breast and other human cancer specimens exhibit reduced SIRT3 levels. These results identify SIRT3 as a genomically expressed, mitochondria-localized tumor suppressor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Our finding that loss of SIRT3 loss drives senescence appears to contradict a report in which cells from SIRT3 knockout mice were highly susceptible to oncogenic transformation; however, this susceptibility depended on the elevated ROS characteristic of sirt3−/− cells (Kim et al., 2010).”
From Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype (2016) · cites this paper as Kim et al., 2010
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the genes encoding SIRT3 and SIRT6 are tumor suppressors”
From Influence of Metabolism on Epigenetics and Disease (2013) · cites this paper as Kim et al., 2010
Experimental — accuracy not yet measuredIn the citing paper
“SIRT3 has been reported as pro-apoptotic ((Allison and Milner 2007)) and SIRT3 loss is associated with a tumor-permissive environment via the inhibition of ROS production ((Kim et al. 2010);(Bell et al. 2011);(Finley et al. 2011)).”
From The Mitochondrial Acylome Emerges: Proteomics, Regulation by Sirtuins, and Metabolic and Disease Implications (2018) · cites this paper as Kim et al. 2010
In the citing paper
“Specifically, SirT3 deficiency alone is sufficient for the transformation of primary MEFs with Myc and/or RAS to from tumors in xenograft models.”
From SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production (2011) · cites this paper as Kim et al., 2010
In the citing paper
“Kim and colleagues also demonstrated that SirT3−/− Myc/Ras MEFs exhibit increased glycolysis, decreased oxidative phosphorylation and increased ROS.”
From SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production (2011) · cites this paper as Kim et al., 2010
In the citing paper
“Recently SirT3 was described to act as a mitochondrial localized tumor suppressor (Kim et al., 2010).”
From SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production (2011) · cites this paper as Kim et al., 2010
In the citing paper
“Previously, SirT3 has been demonstrated to act as a tumor suppressor by negatively regulating MnSOD/ROS-mediated genomic instability (Kim et al., 2010).”
From SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production (2011) · cites this paper as Kim et al., 2010
In the citing paper
“Another member of the sirtuin family, SIRT3, is critical to the maintenance of mitochondria and metabolism and controls ROS production during HSC aging29.”
From Stem cell aging: mechanisms, regulators and therapeutic opportunities (2014) · cites this paper as [29]
In the citing paper
“Likewise, mitochondrial function, largely regulated by sirtuins, not only affects stem cell functions directly but also causes secondary effects on ROS and nutrient-sensing activities, which further modulate stem cell phenotypes29,30,108,113,184.”
From Stem cell aging: mechanisms, regulators and therapeutic opportunities (2014) · cites this paper as [29]
In the citing paper
“Recent work demonstrates that mitochondrial ROS directly contribute to cellular transformation induced by either Ras or Myc overexpression.”
From Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes (2010) · cites this paper as [72]
In the citing paper
“Moreover, Sirt3−/− murine fibroblasts display increased levels of mitochondrial ROS accumulation (compared to wild-type cells) when either Myc or Ras oncogenes are expressed.”
From Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes (2010) · cites this paper as [72]
In the citing paper
“The NAD-dependent deacetylase sirtuin 3 (SIRT3) acts as a tumor suppressor through its regulation of FOXO activity and ROS maintenance 72.”
From Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes (2010) · cites this paper as [72]
In the citing paper
“This ROS accumulation is associated with decreased flux through mitochondrial complexes I and III (possibly allowing for increased escape of electrons to O2), and reduced cellular levels of SOD2 72.”
From Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes (2010) · cites this paper as [72]
In the citing paper
“Expression of SOD2 inhibited this oncogene-mediated transformation of Sirt3−/− cells, suggesting that mitochondrial ROS play an important role in the Sirt3−/− phenotype.”
From Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes (2010) · cites this paper as [72]
In the citing paper
“These finding are consistent with observations in Sod2−/− fibroblasts, which like their Sirt3−/− counterparts, are capable of transformation with single oncogenes 72.”
From Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes (2010) · cites this paper as [72]
In the citing paper
“Sirt3−/− cells become transformed after expression of either Myc or Ras, whereas wild-type cells require expression of both oncogenes.”
From Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes (2010) · cites this paper as [72]
In the citing paper
“SIRT3 deacetylates FOXO3a, promoting its nuclear localization and transcriptional activation 40, 72.”
From Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes (2010) · cites this paper as [72]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 2×
“It has been previously shown that overexpression of Myc in primary cells results in massive programmed cell death, whereas overexpression of Ras induces premature senescence (Sebastian et al., 2005; Serrano et al., 1997).”
BackgroundCancer cell metabolism: warburg and beyond
Hsu, P. P., & Sabatini, D. M. (2008) · Cell · doi:10.1016/j.cell.2008.08.021 · Cited by 2,452 · cited 2×
“Mitochondrial abnormalities associated with altered oxidative metabolism are observed in tumor cells in vitro and in vivo and appear to contribute to a chronic condition of oxidative stress (Hsu and Sabatini, 2008).”
BackgroundRhodes, D. R., Sundaram, S. K., Mahavisno, V., Varambally, R., Yu, J., Briggs, B., Barrette, T. R., Anstett, M. J., Kincead-Beal, C., Kulkarni, P., et al. (2007) · Neoplasia · doi:10.1593/neo.07112 · Cited by 2,057
Sotiriou, C. P., Wirapati, P., Loi, S., Harris, A. L., Fox, S., Smeds, J., Nordgren, H., Farmer, P. J., Praz, V., Haibe‐Kains, B., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj052 · Cited by 2,050
Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans
Tissenbaum, H. A., & Guarente, L. (2001) · Nature · doi:10.1038/35065638 · Cited by 1,603
Recent progress in the biology and physiology of sirtuins
Finkel, T., Deng, C., & Mostoslavsky, R. (2009) · Nature · doi:10.1038/nature08197 · Cited by 1,506
Self-citationSir2 mediates longevity in the fly through a pathway related to calorie restriction
Rogina, B., & Helfand, S. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404184101 · Cited by 1,361
Genetic pathways that regulate ageing in model organisms
Guarente, L., & Kenyon, C. J. (2000) · Nature · doi:10.1038/35041700 · Cited by 1,337
Cited by
Sorted by citations
Items 201–300 of 788
Mitochondrial Sirt3 contributes to the bone loss caused by aging or estrogen deficiency
Ling, W., Krager, K. J., Richardson, K. K., Warren, A. D., Ponte, F., Aykin‐Burns, N., Manolagas, S. C., Almeida, M., & Kim, H. (2021) · JCI Insight · doi:10.1172/jci.insight.146728 · Cited by 104
Self-citationSirt3 inhibits hepatocellular carcinoma cell growth through reducing Mdm2-mediated p53 degradation
Zhang, Y., & Zhou, L. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.05.053 · Cited by 102
Nutrient Sensing and the Oxidative Stress Response
Luo, H., Chiang, H.-H., Louw, M., Susanto, A., & Chen, D. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.02.008 · Cited by 107
Post-translational modifications of FOXO family proteins
Wang, Z., Yu, T., & Huang, P. C. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5867 · Cited by 107
SIRT3-Mediated Dimerization of IDH2 Directs Cancer Cell Metabolism and Tumor Growth
Zou, X., Zhu, Y., Park, S., Liu, G., O’Brien, J., Jiang, H., & Gius, D. R. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2393 · Cited by 106
Self-citationNegative reciprocal regulation between Sirt1 and Per2 modulates the circadian clock and aging
Wang, R.-H., Zhao, T., Cui, K., Hu, G., Chen, Q., Chen, W., Wang, X. W., Soto–Gutiérrez, A., Zhao, K., & Deng, C. (2016) · Scientific Reports · doi:10.1038/srep28633 · Cited by 103
Self-citationKao, Y.-Y., Chou, C., Yeh, L.-Y., Chen, Y., Chang, K., Liu, C., Chiang, C. F., & Lin, S. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.04.028 · Cited by 98
SIRT3 Enhances Glycolysis and Proliferation in SIRT3-Expressing Gastric Cancer Cells
Cui, Y., Qin, L., Wu, J., Qu, X., Hou, C., Sun, W., Li, S., Vaughan, A. T., Li, J. J., & Liu, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129834 · Cited by 100
Mitochondrial DNA mutations and breast tumorigenesis
Yadav, N., & Chandra, D. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.10.002 · Cited by 96
HDAC as onco target: Reviewing the synthetic approaches with SAR study of their inhibitors
Sangwan, R., Rajan, R., & Mandal, P. K. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.08.073 · Cited by 97
Wang, J., Nisar, M., Huang, C., Pan, X., Lin, D., Zheng, G., Jin, H., Chen, D., Tian, N., Huang, Q., et al. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0173-3 · Cited by 97
Lu, J., Zhang, H., Chen, X., Zou, Y., Li, J., Wang, L., Wu, M., Zang, J., Yu, Y., Zhuang, W., et al. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.07.012 · Cited by 93
The role of sirtuins in modulating redox stressors
Webster, B. R., Lu, Z., Sack, M. N., & Scott, I. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.484 · Cited by 95
Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies
Yu, W., Denu, R. A., Krautkramer, K. A., Grindle, K. M., Yang, D. T., Asimakopoulos, F. A., Hematti, P., & Denu, J. M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.702076 · Cited by 97
Mitohormesis Primes Tumor Invasion and Metastasis
Kenny, T. C., Craig, A. J., Villanueva, A., & Germain, D. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.04.095 · Cited by 102
Yi, Y. W., Kang, H. J., Kim, H. J., Kong, Y., Brown, M. L., & Bae, I. (2013) · Oncotarget · doi:10.18632/oncotarget.1070 · Cited by 95
Self-citationSIRT5: A Safeguard Against Oxidative Stress-Induced Apoptosis in Cardiomyocytes
Liu, B., Che, W., Zheng, C., Liu, W., Wen, J., Fu, H., Tang, K., Zhang, J., & Xu, Y. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000354505 · Cited by 93
Mitochondrial longevity pathways
Vendelbo, M. H., & Nair, K. S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.029 · Cited by 92
The complex role of SIRT6 in carcinogenesis
Lerrer, B., Gertler, A. A., & Cohen, H. Y. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv167 · Cited by 91
Chen, X., Hao, B., Li, D. X., Reiter, R. J., Bai, Y., Abay, B., Chen, G., Lin, S., Zheng, T., Ren, Y., et al. (2021) · Journal of Pineal Research · doi:10.1111/jpi.12755 · Cited by 92
Lombard, D. B., & Zwaans, B. M. M. (2013) · Gerontology · doi:10.1159/000354382 · Cited by 94
Honokiol ameliorates cisplatin‐induced acute kidney injury via inhibition of mitochondrial fission
Mao, R.-W., He, S., Lan, J., & Zhu, W. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15837 · Cited by 91
Wei, L., Zhou, Y., Qiao, C., Ni, T., Li, Z., You, Q., Guo, Q., & Lu, N. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.86 · Cited by 90
SIRT3 Deacetylates Ceramide Synthases
Novgorodov, S. A., Riley, C. L., Keffler, J. A., Yu, J., Kindy, M. S., Macklin, W. B., Lombard, D. B., & Gudz, T. I. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.668228 · Cited by 86
Ketogenic diet induces p53-dependent cellular senescence in multiple organs
Wei, S., Schell, J. R., Chocrón, E. S., Varmazyad, M., Xu, G., Chen, W. H., Martinez, G. M., Dong, F. F., Sreenivas, P., Trevino, R., et al. (2024) · Science Advances · doi:10.1126/sciadv.ado1463 · Cited by 90
Self-citationChang, G., Chen, Y., Zhang, H., & Zhou, W. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.03.056 · Cited by 86
Resveratrol’s Anti-Cancer Effects through the Modulation of Tumor Glucose Metabolism
Brockmueller, A., Sameri, S., Líšková, A., Zhai, K., Varghese, E., Samuel, S. M., Büsselberg, D., Kubatka, P., & Shakibaei, M. (2021) · Cancers · doi:10.3390/cancers13020188 · Cited by 89
Wu, Y., Lee, H., Liao, C., & Wei, Y. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.10.002 · Cited by 85
Mitochondrial longevity pathways
Raffaello, A., & Rizzuto, R. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.10.007 · Cited by 72
Sirtuin 3 (SIRT3) maintains bone homeostasis by regulating AMPK-PGC-1β axis in mice
Huh, J.-E., Shin, J. H., Jang, E., Park, S. J., Park, D. R., Ko, R., Seo, D.-H., Kim, H. S., Lee, S. H., Choi, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep22511 · Cited by 88
Self-citationInhibition of epithelial cell migration and Src/FAK signaling by SIRT3
Lee, J. J., van de Ven, R. A. H., Zaganjor, E., Ng, M. R., Barakat, A., Demmers, J. J. P. G., Finley, L. W. S., Herrera, K. N. G., Hung, Y. P., Harris, I. S., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1800440115 · Cited by 89
Park, S., Zhu, Y., Özden, Ö., Kim, H. S., Jiang, H., Deng, C., Gius, D. R., & Vassilopoulos, A. (2012) · PubMed · Cited by 85
Self-citationHe, X., Zeng, H., & Chen, J. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.04.092 · Cited by 84
Son, M. J., Kwon, Y., Son, T., & Cho, Y. S. (2016) · Stem Cells · doi:10.1002/stem.2460 · Cited by 85
Torrens‐Mas, M., Pons, D. G., Sastre‐Serra, J., Oliver, J., & Roca, P. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25653 · Cited by 88
SOD2 acetylation on lysine 68 promotes stem cell reprogramming in breast cancer
He, C., Danes, J. M., Hart, P. C., Zhu, Y., Huang, Y., de Abreu, A. L., O’Brien, J., Mathison, A., Tang, B., Frasor, J. M., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1902308116 · Cited by 83
Self-citationSirtuins and the Metabolic Hurdles in Cancer
German, N. J., & Haigis, M. C. (2015) · Current Biology · doi:10.1016/j.cub.2015.05.012 · Cited by 84
SIRT3 regulates cellular iron metabolism and cancer growth by repressing iron regulatory protein 1
Jeong, S. M., Lee, J. J., Finley, L. W. S., Schmidt, P. J., Fleming, M. D., & Haigis, M. C. (2014) · Oncogene · doi:10.1038/onc.2014.124 · Cited by 87
Tamoxifen regulates cell fate through mitochondrial estrogen receptor beta in breast cancer
Razandi, M., Pedram, A., Jordan, V. C., Fuqua, S. A. W., & Levin, E. R. (2012) · Oncogene · doi:10.1038/onc.2012.335 · Cited by 85
Wang, J., Wang, K., Huang, C., Lin, D., Zhou, Y., Wu, Y., Tian, N., Fan, P., Pan, X., Xu, D., et al. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.27746 · Cited by 83
Zwaans, B. M. M., & Lombard, D. B. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.016287 · Cited by 81
Mitochondrial Sirtuins in Cancer: Emerging Roles and Therapeutic Potential
George, J., & Ahmad, N. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2733 · Cited by 81
Subcellular compartmentalization of NAD+ and its role in cancer: A sereNADe of metabolic melodies
Zhu, Y., Liu, J., Park, J., Rai, P., & Zhai, R. G. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.04.002 · Cited by 82
Desouki, M. M., Doubinskaia, I., Gius, D. R., & Abdulkadir, S. A. (2014) · Human Pathology · doi:10.1016/j.humpath.2014.01.004 · Cited by 80
Self-citationMitochondrial Redox Signaling and Tumor Progression
Chen, Y., Zhang, H., Zhou, H. J., Ji, W., & Wang, M. (2016) · Cancers · doi:10.3390/cancers8040040 · Cited by 80
Targeting SIRT3 sensitizes glioblastoma to ferroptosis by promoting mitophagy and inhibiting SLC7A11
Li, X., Zhang, W., Xing, Z., Hu, S., Zhang, G., Wang, T., Wang, T., Fan, Q., Chen, G., Cheng, J., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06558-0 · Cited by 80
Dysregulated glycolysis as an oncogenic event
Mikawa, T., LLeonart, M. E., Takaori‐Kondo, A., Inagaki, N., Yokode, M., & Kondoh, H. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1840-3 · Cited by 85
Reiter, R. J., Sharma, R., Ma, Q., Rosales‐Corral, S., & Chuffa, L. G. D. A. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03438-1 · Cited by 80
Liu, L., Peritore, C., Rogers, J. G., Kayhan, M. A., & Dönmez, G. (2015) · Neurochemical Research · doi:10.1007/s11064-014-1507-8 · Cited by 79
Sirtuins, Metabolism, and Cancer
Martínez-Pastor, B., & Mostoslavsky, R. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00022 · Cited by 81
Profilin-1 suppresses tumorigenicity in pancreatic cancer through regulation of the SIRT3-HIF1α axis
Yao, W., Ji, S., Qin, Y., Yang, J., Xu, J., Zhang, B., Xu, W., Liu, J., Shi, S., Liu, L., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-187 · Cited by 79
Sirt3-mediated mitophagy protects tumor cells against apoptosis under hypoxia
Qiao, A., Wang, K., Yuan, Y., Guan, Y., Ren, X., Li, L., Chen, X., Feng, L., Chen, A. F., Zhou, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9717 · Cited by 78
Quan, Y., Wang, N., Chen, Q., Xu, J., Cheng, W., Di, M., Xia, W., & Gao, W. (2015) · Oncotarget · doi:10.18632/oncotarget.4764 · Cited by 76
Zhu, Y., Yan, Y., Principe, D. R., Zou, X., Vassilopoulos, A., & Gius, D. R. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-15 · Cited by 77
Self-citationSIRT3 protects cells from hypoxia via PGC-1α- and MnSOD-dependent pathways
Wang, Q., Li, L., Li, C. Y., Pei, Z., Zhou, M., & Li, N. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.11.045 · Cited by 77
Cardiac mitochondrial energy metabolism in heart failure: Role of cardiolipin and sirtuins
Dolinsky, V. W., Cole, L., Sparagna, G. C., & Hatch, G. M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.03.008 · Cited by 78
SIRT3 Overexpression Inhibits Growth of Kidney Tumor Cells and Enhances Mitochondrial Biogenesis
Liu, H., Li, S., Liu, X., Chen, Y., & Deng, H. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00260 · Cited by 78
Adjudin protects rodent cochlear hair cells against gentamicin ototoxicity via the SIRT3-ROS pathway
Quan, Y., Li, X., Shao, J., Yin, S., Cheng, C. Y., Xia, W., & Gao, W. (2015) · Scientific Reports · doi:10.1038/srep08181 · Cited by 75
Consiglio, M., Destefanis, M., Morena, D., Foglizzo, V., Forneris, M., Pescarmona, G., & Silvagno, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115816 · Cited by 74
Mitochondrial Superoxide Dismutase - Signals of Distinction
Miriyala, S., Holley, A. K., & Clair, D. K. S. (2011) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152011795255920 · Cited by 74
Sirtuins in Cancer: a Balancing Act between Genome Stability and Metabolism
Jeong, S. M., & Haigis, M. C. (2015) · Molecules and Cells · doi:10.14348/molcells.2015.0167 · Cited by 74
Nadal‐Serrano, M., Pons, D. G., Sastre‐Serra, J., Blanquer-Rosselló, M. D. M., Roca, P., & Oliver, J. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.07.002 · Cited by 73
Zhang, C. Z., Liu, L., Cai, M., Pan, Y., Fu, J., Cao, Y., & Yun, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051703 · Cited by 73
SIRT3 Controls Cancer Metabolic Reprogramming by Regulating ROS and HIF
Schumacker, P. T. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.03.001 · Cited by 73
SirT3 and p53 Deacetylation in Aging and Cancer
Chen, J., Wang, A., & Chen, Q. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25669 · Cited by 73
Targeting the duality of cancer
Arbiser, J. L., Bonner, M. Y., & Gilbert, L. C. (2017) · npj Precision Oncology · doi:10.1038/s41698-017-0026-x · Cited by 72
FOXO3a in cancer drug resistance
Liu, Y., Wang, Y., Li, X., Jia, Y., Wang, J., & Ao, X. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215724 · Cited by 72
Sirt3 is a tumor suppressor in lung adenocarcinoma cells
Xiao, K., Jiang, J., Wang, W., Cao, S., ZHU, L., Zeng, H., Ouyang, R., Zhou, R., & Chen, P. (2013) · Oncology Reports · doi:10.3892/or.2013.2604 · Cited by 72
Using mitochondrial sirtuins as drug targets: disease implications and available compounds
Gertz, M., & Steegborn, C. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2180-7 · Cited by 73
SIRT3: A Central Regulator of Mitochondrial Adaptation in Health and Disease
Weir, H. J. M., Lane, J. D., & Balthasar, N. (2013) · Genes & Cancer · doi:10.1177/1947601913476949 · Cited by 76
Wagner, G. R., Pride, P. M., Babbey, C. M., & Payne, R. M. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds095 · Cited by 71
SIRT3 Acts as a Neuroprotective Agent in Rotenone-Induced Parkinson Cell Model
Zhang, J., Deng, Y., Zhang, M., Su, H., & Qu, Q. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1892-2 · Cited by 70
Emerging concepts in liver graft preservation
Béjaoui, M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i2.396 · Cited by 70
Sirtuin-3 (SIRT3) and the Hallmarks of Cancer
Alhazzazi, T. Y., Kamarajan, P., Verdin, E. M., & Kapila, Y. L. (2013) · Genes & Cancer · doi:10.1177/1947601913486351 · Cited by 69
Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
Li, H., Gan, Y., Shi, R., Lang, B., Chen, X., Xia, D., Xiao, H., Guo, X., Guan, W., Ye, Z., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-8 · Cited by 70
Reduced mitochondrial function in obesity-associated fatty liver: SIRT3 takes on the fat
Choudhury, M., Jonscher, K. R., & Friedman, J. E. (2011) · Aging · doi:10.18632/aging.100289 · Cited by 68
Identification of a sirtuin 3 inhibitor that displays selectivity over sirtuin 1 and 2
Galli, U., Mesenzani, O., Coppo, C., Sorba, G., Canonico, P. L., Tron, G. C., & Genazzani, A. A. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.07.001 · Cited by 68
Bugga, P., Alam, J., Kumar, R., Pal, S., Chattopadhyay, N., & Banerjee, S. K. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110309 · Cited by 69
Zhao, K., Zhou, Y., Qiao, C., Ni, T., Li, Z., Wang, X., Guo, Q., Lu, N., & Wei, L. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0137-1 · Cited by 68
Song, C.-L., Tang, H., Ran, L.-K., Ko, B. C. B., Zhang, Z.-Z., Chen, X. '., Ren, J.-H., Tao, N.-N., Wy, L., Huang, A.-L., et al. (2015) · Oncogene · doi:10.1038/onc.2015.121 · Cited by 68
Shan, W., Jiang, Y., Yu, H., Huang, Q., Liu, L., Guo, X., Li, L., Mi, Q., Zhang, K., & Yang, Z.-Q. (2017) · Europe PMC (PubMed Central) · Cited by 68
Regulation of skeletal muscle oxidative capacity and muscle mass by SIRT3
Lin, L., Chen, K., Khalek, W. A., Ward, J. L., Yang, H., Chabi, B., Wrutniak-Cabello, C., & Tong, Q. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085636 · Cited by 67
Bao, J., & Sack, M. N. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0402-y · Cited by 67
Somatic alterations in mitochondrial DNA and mitochondrial dysfunction in gastric cancer progression
Lee, H. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i14.3950 · Cited by 70
Costa‐Machado, L. F., & Fernández-Marcos, P. J. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1634953 · Cited by 66
Mitochondrial metabolism as a regulator of keratinocyte differentiation
Hamanaka, R. B., & Chandel, N. S. (2013) · Cellular Logistics · doi:10.4161/cl.25456 · Cited by 67
Liu, C., Huang, Z.-H., Jiang, H., & Shi, F. (2014) · BioMed Research International · doi:10.1155/2014/871263 · Cited by 67
Involvement of free radicals in breast cancer
Ríos‐Arrabal, S., Artacho‐Cordón, F., León, J., Elisa, R.-M., Salinas-Asensio, M. D. M., Calvente, I., & Núñez, M. I. (2013) · SpringerPlus · doi:10.1186/2193-1801-2-404 · Cited by 72
Gleave, J. A., Arathoon, L. R., Trinh, D., Lizal, K. E., Giguère, N., Barber, J., Najarali, Z., Khan, M. H., Thiele, S. L., Semmen, M. S., et al. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.06.009 · Cited by 66
The Role of SIRT3 in the Brain Under Physiological and Pathological Conditions
Sidorova‐Darmos, E., Sommer, R., & Eubanks, J. H. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00196 · Cited by 66
Xu, L., Li, Y., Zhou, L., Dorfman, R. G., Liu, L., Cai, R., Jiang, C., Tang, D., Wang, Y., Zou, X., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.2089 · Cited by 66
Jayatunga, D. P. W., Hone, E., Khaira, H., Lunelli, T., Singh, H., Guillemin, G. J., Fernando, B., Garg, M. L., Verdile, G., & Martins, R. N. (2021) · Nutrients · doi:10.3390/nu13113744 · Cited by 67
Genealogy of an ancient protein family: the Sirtuins, a family of disordered members
Costantini, S., Sharma, A., Raucci, R., Costantini, M., Autiero, I., & Colonna, G. (2013) · BMC Evolutionary Biology · doi:10.1186/1471-2148-13-60 · Cited by 66
Regulation of mammalian mitochondrial translation by post-translational modifications
Koc, E. C., & Koç, H. (2012) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2012.03.003 · Cited by 66
Zhu, Y., Park, S., Özden, Ö., Kim, H., Jiang, H., Vassilopoulos, A., Spitz, D. R., & Gius, D. R. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.06.020 · Cited by 66
Self-citationMa, C., Sun, Y., Pi, C., Wang, H., Sun, H., Yu, X., Shi, Y., & He, X. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.599376 · Cited by 68
Oxidative stress and inflammation regulation of sirtuins: New insights into common oral diseases
Pan, Z., Dong, H., Huang, N., & Fang, J. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.953078 · Cited by 67
The role of SIRT3 in mitochondrial homeostasis and cardiac adaptation to hypertrophy and aging
Sack, M. N. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.11.004 · Cited by 66
Sirt3 deficiency accelerates ovarian senescence without affecting spermatogenesis in aging mice
Zhu, J., Yang, Q., Li, H., Wang, Y., Jiang, Y., Wang, H., Cong, L., Xu, J., Shen, Z., Chen, W., et al. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.10.324 · Cited by 64
Role of sirtuins in ischemia-reperfusion injury
Pantazi, E. D. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i43.7594 · Cited by 68
Metadata
- Authors
- Kim, H.-S., Patel, K., Muldoon-Jacobs, K., Bisht, K. S., Aykin-Burns, N., Pennington, J. D., van der Meer, R., Nguyen, P., Savage, J., Owens, K. M., Vassilopoulos, A., Ozden, O., Park, S.-H., Singh, K. K., Abdulkadir, S. A., Spitz, D. R., Deng, C.-X., & Gius, D.
- Affiliations
- National Institutes of Health (US)
- Roswell Park Comprehensive Cancer Center (US)
- Vanderbilt University Medical Center (US)
- University of Iowa (US)
- Corresponding author
- Deng, Chu-Xia
- Gius, David
- ORCID
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2010-01
- Volume
- 17
- Issue
- 1
- Pages
- 41-52
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC3711519
- OpenAlex
- W2145755327
- Cited by
- 785
- References
- 35
- Citations by year
- 2026: 11 · 2025: 30 · 2024: 35 · 2023: 20 · 2022: 44 · 2021: 49 · 2020: 44 · 2019: 47 · 2018: 48 · 2017: 56 · 2016: 71 · 2015: 53 · 2014: 61 · 2013: 74 · 2012: 67
- FWCI
- 27.57
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Public Health Service (116430, R01 121904)
- National Institute on Aging (F30AG030839)
- National Cancer Institute (CA094858, CA123484, R01CA116430, R01CA094858, R01CA133114, R01CA100045, R01CA123484, R01CA121904, T32CA078586, P30CA086862)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- SIRT3, sirtuins, tumor suppressor, mitochondria, mitochondrial integrity, mitochondrial metabolism, superoxide, genomic instability, oncogenic transformation, c-Myc, Ras, superoxide dismutase, mammary tumors, breast cancer, cellular stress
- MeSH terms
- Aging, Animals, Breast Neoplasms, Cell Transformation, Neoplastic, Female, Fibroblasts, Humans, Immunohistochemistry, Mitochondria, Stress, Physiological, Superoxides, Genes, Tumor Suppressor, Mice, Knockout, Oxidative Stress, Mice, Sirtuin 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
